Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations

被引:66
|
作者
Van Gele, Mireille [1 ]
Geusens, Barbara [1 ]
Brochez, Lieve [1 ]
Speeckaert, Reinhart [1 ]
Lambert, Jo [1 ]
机构
[1] Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium
关键词
partition coefficient; reconstructed human skin model; skin permeability; stratum corneum; transdermal drug delivery; RECONSTRUCTED HUMAN EPIDERMIS; VITRO PERCUTANEOUS-ABSORPTION; IN-VITRO; STRATUM-CORNEUM; ESTRADIOL PERMEATION; EX-VIVO; SUPERSATURATED SOLUTIONS; ANIMAL SKIN; PENETRATION; METABOLISM;
D O I
10.1517/17425247.2011.568937
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transdermal drug delivery has several known advantages over the oral route and hypodermic injections. The number of drugs that can be taken up transdermally is, however, limited owing to the innate barrier function of the skin. New transdermal drug candidates need to be tested extensively before being used on humans. In this regard, in vitro permeation methods are highly important to predict in vivo permeation of drugs. Areas covered: This review illustrates how different types of reconstructed skin models are being used as alternatives to human and pig skin for in vitro permeation testing of drugs. Insights into how various factors (including the physicochemical nature of molecules and formulations) or skin properties might affect the permeability of drugs in reconstructed skin models are provided. Also, opportunities and pitfalls of reconstructed skin models are highlighted. Expert opinion: Many studies have revealed that the permeability of reconstructed skin models is much higher compared with human excised skin. This is in accordance with the incomplete barrier found in these models. Nevertheless, the reconstructed skin models available today are useful tools for estimating the rank order of percutaneous absorption of a series of compounds with different physicochemical properties. A major challenge in the further development of reconstructed skin models for drug delivery studies is to obtain a barrier function similar to in vivo skin. Whether this goal will be achieved in the near future is uncertain and will be, in the authors' opinion, a very difficult task.
引用
收藏
页码:705 / 720
页数:16
相关论文
共 50 条
  • [41] The role of nanocarriers for transdermal application targeted to lymphatic drug delivery: Opportunities and challenges
    De Oliveira, Thaisa C.
    Tavares, Maria E., V
    Soares-Sobrinho, Jose L.
    Chaves, Luise L.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 68
  • [42] New trends in mechanistic transdermal drug delivery modelling: Towards an accurate geometric description of the skin microstructure
    Sebastia-Saez, Daniel
    Burbidge, Adam
    Engmann, Jan
    Ramaioli, Marco
    COMPUTERS & CHEMICAL ENGINEERING, 2020, 141
  • [43] Beyond Skin Deep: Phospholipid-Based Nanovesicles as Game-Changers in Transdermal Drug Delivery
    Akl, Mohamed A.
    Eldeen, Muhammad Alaa
    Kassem, Abdulsalam M.
    AAPS PHARMSCITECH, 2024, 25 (06):
  • [44] Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
    Qu, Fei
    Geng, Rui
    Liu, Yijing
    Zhu, Jintao
    THERANOSTICS, 2022, 12 (07): : 3372 - 3406
  • [45] Skin tolerability associated with transdermal drug delivery systems: an overview
    Iris Ale
    Jean-Marie Lachapelle
    Howard I. Maibach
    Advances in Therapy, 2009, 26 : 920 - 935
  • [46] Transdermal Drug Delivery by Microneedles: Does Skin Metabolism Matter?
    Al-Qallaf, Barrak
    Mori, Daisuke
    Olatunji, Lola
    Das, Diganta Bhusan
    Cui, Zhanfeng
    INTERNATIONAL JOURNAL OF CHEMICAL REACTOR ENGINEERING, 2009, 7
  • [47] A Skin-Contact-Actuated Micropump for Transdermal Drug Delivery
    Mousoulis, Charilaos
    Ochoa, Manuel
    Papageorgiou, Demetrios
    Ziaie, Babak
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2011, 58 (05) : 1492 - 1498
  • [48] Skin tolerability associated with transdermal drug delivery systems: an overview
    Ale, Iris
    Lachapelle, Jean-Marie
    Maibach, Howard I.
    ADVANCES IN THERAPY, 2009, 26 (10) : 920 - 935
  • [49] Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
    Brito, Sofia
    Baek, Moonki
    Bin, Bum-Ho
    PHARMACEUTICS, 2024, 16 (11)
  • [50] Skin adhesives and skin adhesion 1. Transdermal drug delivery systems
    Venkatraman, S
    Gale, R
    BIOMATERIALS, 1998, 19 (13) : 1119 - 1136